SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-039953
Filing Date
2021-08-03
Accepted
2021-08-03 07:20:41
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sage-10q_20210630.htm   iXBRL 10-Q 3028118
2 EX-31.1 sage-ex311_7.htm EX-31.1 9330
3 EX-31.2 sage-ex312_8.htm EX-31.2 9281
4 EX-32.1 sage-ex321_9.htm EX-32.1 8640
5 GRAPHIC gruy5ricsbvc000001.jpg GRAPHIC 195853
  Complete submission text file 0001564590-21-039953.txt   10042180

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sage-20210630.xsd EX-101.SCH 53554
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20210630_cal.xml EX-101.CAL 43564
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20210630_def.xml EX-101.DEF 204296
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20210630_lab.xml EX-101.LAB 411202
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20210630_pre.xml EX-101.PRE 328160
11 EXTRACTED XBRL INSTANCE DOCUMENT sage-10q_20210630_htm.xml XML 1901397
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 211137967
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences